Yang, B., Zhou, H., Yang, H., Chen, Z., Sun, C., Ni, S., Peng, P., Sheng, Z., Du, X., Wang, J., Wang, P., Zhang, H., Liao, M., Gou, Z., Wei, F., Fan, J., Wang, J. (2025). Phase 1 study of TT-00973-MS, a highly selective and potent AXL inhibitor, in patients with advanced solid tumors.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.3106